Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 42,592,060 $ 31,803,387
Cost of sales 11,805,202 10,146,565
Gross profit 30,786,858 21,656,822
Operating expenses:    
Research and development 16,935,222 13,743,826
Selling, general and administrative 14,498,330 14,348,890
Impairment of intangible assets 14,100,000  
Total operating expenses 45,533,552 28,092,716
Operating loss (14,746,694) (6,435,894)
Non-operating (expenses) income:    
Interest expense (4,621,422) (4,706,056)
Change in fair value of derivative liabilities (557,000) (1,199,000)
Other (expense) income, net (126,860) 19,651
Total non-operating expenses (5,305,282) (5,885,405)
Loss before income taxes (20,051,976) (12,321,299)
Income tax benefit (1,078,441) (303,933)
Net loss $ (18,973,535) $ (12,017,366)
Net loss per basic and diluted common share outstanding $ (0.28) $ (0.19)
Basic and diluted weighted average common shares outstanding 66,753,450 63,323,127